Alterations of the PTEN gene occur in 35% of endometrial cancers, 32% of glial tumors, 17% of prostate cancers, 12% of non-small-cell lung cancer, and 9% of breast cancers [131]. This evidence concerns the gene PTEN and prostate cancer.